Director
Randall J. Bateman, MD
Charles F. and Joanne Knight Distinguished Professor of Neurology
Randall Bateman, MD, is the Charles F. and Joanne Knight Distinguished Professor of Neurology, director of the Dominantly Inherited Alzheimer Network (DIAN), director of the DIAN Trials Unit (DIAN-TU), principal investigator of the Bateman Lab and director of the Tracy Family Stable Isotope Labeling Quantitation (SILQ) Center for Neurodegenerative Biology.
Assistant director
Chihiro Sato, PhD
Assistant Professor of Neurology
- Phone: 314-273-7734
- Email: satochihiro@nospam.wustl.edu
Chihiro Sato is an assistant professor in the Department of Neurology and an NIH K01 scholar. She is currently researching the kinetics of tau in the human central nervous system in vivo and in vitro. She is also interested in studying tau profile in Alzheimer’s disease and various tauopathies hoping to improve early diagnostics.
Nicolas Barthélemy, PhD
Assistant Professor
- Phone: 314-362-3429
- Email: barthelemy.nicolas@wustl.edu
Nicolas Barthélemy obtained his PhD in analytical chemistry from the University of Strasbourg. He specializes in protein characterization and quantitation by mass spectrometry. He joined the Bateman laboratory as postdoctoral associate in 2015. As research instructor, Barthélemy focuses his research on tau protein phosphorylation in Alzheimer’s disease and tau modifications in other tauopathies. His research led to the discovery of new tau biomarkers for AD, including ptau217 in plasma/spinal fluid, and has provided new understanding on molecular mechanisms involved in tauopathies.
Kanta Horie, PhD
Voluntary Research Associate Professor
- Phone: 314-273-7733
- Email: horiekanta@wustl.edu
Kanta Horie is a translational neuroscientist with expertise in analytical chemistry and mass spectrometry. He obtained his PhD in pharmacy from Kyoto University and specializes in proteomics research. He currently holds a faculty position at WashU Medicine Department of Neurology and leads the translational science in Eisai as a department head. He is uniquely positioned to perform biomarker research that bridges the gap between academia and industry.
Justin Melendez, PhD
Post-Doctoral Researcher
- Email: justin.melendez@wustl.edu
Justin Melendez received his PhD in genetics and genomics from Washington University in St. Louis where he worked on developing tools for molecular biology and sequencing technologies. His work in the Bateman lab focuses on studying the connection between human aging and neurodegenerative disease, understanding how and why we age and developing therapeutic interventions to extend human life and health span.
Soumya Mukherjee, PhD
Assistant Professor of Neurology
- Email: msoumya@wustl.edu
Soumya Mukherjee is a research instructor in the Department of Neurology at Washington University in St. Louis. He obtained his PhD in chemistry from the University of Calcutta and specializes in proteomics and mass spectrometry. He joined the Bateman lab in 2022. His current research interests are in understanding the molecular mechanisms in neurodegeneration and the role protein post-translational modifications (PTMs) has to play during disease progression. Specifically he is interested in the 1) cross-talk of PTMs during disease staging, 2) protein aging and 3) altered proteoforms in neurodegenerative diseases. His goals are in translation of these findings using analytical techniques for the development of disease biomarkers.